Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Medium-wave-sensitive opsin 2 (OPN1MW2) is an opsin-family G protein-coupled receptor, expressed in the cone photoreceptor cells of the retina and enabling perception of medium-wavelength (green/yellow) light. The OPN1MW2 gene is a common tandem duplication event on the X chromosome, with only the first copy generally expressed. The protein consists of seven transmembrane domains, forming the chromophore-binding site for cis-retinal. In response to photon absorption, OPN1MW2 initiates the phototransduction cascade required for color vision. Defects or structural rearrangements in OPN1MW2 underlie red-green color blindness, the most frequent form of inherited color vision deficiency. Medium-wave-sensitive opsin 2 is essential for green light perception and is evolutionarily related to other visual opsins. It is not a common drug target, and clinical interest centers on genetic diagnosis rather than pharmacological modulation.
Not applicable. No drugs are known to clinically act on this Opsin; photopigments are typically activated by light (photons) rather than exogenous ligands
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Medium-wave-sensitive opsin 2 (OPN1MW2).